IKBIP, a novel glioblastoma biomarker, maintains abnormal proliferation of tumor cells by inhibiting the ubiquitination and degradation of CDK4.
Li K, Huang G, Wang Z, Yang R, Zhang W, Ni B, Guan J, Yi G, Li Z, Zhu Q, et al. Biochim Biophys Acta Mol Basis Dis. 2023 Jan 1; 1869(1):166571. Epub 2022 Oct 14.